Predictive Oncology Management
Management criteria checks 4/4
Predictive Oncology's CEO is Raymond Vennare, appointed in Nov 2022, has a tenure of 3.17 years. total yearly compensation is $525.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth €4.71K. The average tenure of the management team and the board of directors is 2 years and 3.8 years respectively.
Key information
Raymond Vennare
Chief executive officer
US$525.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 2yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$14m |
| Jun 30 2024 | n/a | n/a | -US$14m |
| Mar 31 2024 | n/a | n/a | -US$15m |
| Dec 31 2023 | US$525k | US$525k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$17m |
| Jun 30 2023 | n/a | n/a | -US$19m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$639k | US$88k | -US$26m |
| Sep 30 2022 | n/a | n/a | -US$26m |
| Jun 30 2022 | n/a | n/a | -US$27m |
| Mar 31 2022 | n/a | n/a | -US$19m |
| Dec 31 2021 | US$33k | n/a | -US$20m |
Compensation vs Market: Raymond's total compensation ($USD525.00K) is about average for companies of similar size in the German market ($USD474.67K).
Compensation vs Earnings: Raymond's compensation has been consistent with company performance over the past year.
CEO
Raymond Vennare (71 yo)
2yrs
Tenure
US$525,000
Compensation
Mr. Raymond F. Vennare is Chief Executive Officer and Chairman at Predictive Oncology Inc. from November 01, 2022. He Co-Founded ThermalTherapeutic Systems, Inc. in 2006 and served as its Executive Vice Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 2yrs | US$525.00k | 0.11% € 4.7k | |
| Interim Chief Financial Officer | 1.2yrs | no data | no data | |
| Senior Director of Marketing | 2.6yrs | no data | no data | |
| Senior Vice President of Biologics | no data | no data | no data | |
| Senior VP of Translational Medicine & Drug Discovery and Medical Director | no data | no data | no data |
2.0yrs
Average Tenure
Experienced Management: S1K's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 3.2yrs | US$525.00k | 0.11% € 4.7k | |
| Member of Business Advisory Board | 1.4yrs | no data | no data | |
| Lead Independent Director | 4.3yrs | US$98.90k | no data | |
| Member of Business Advisory Board | 1.4yrs | no data | no data | |
| Independent Director | 1.5yrs | US$73.34k | 0.14% € 6.0k | |
| Member of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Independent Director | 4.8yrs | US$54.45k | 0.28% € 12.3k | |
| Member of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Independent Director | 2yrs | US$65.56k | 0.14% € 6.3k | |
| Independent Director | 4.3yrs | US$76.67k | 0.32% € 14.1k | |
| Independent Director | 4.3yrs | US$65.56k | 0.34% € 14.9k | |
| Member of Scientific Advisory Board | 1.6yrs | no data | no data |
3.8yrs
Average Tenure
64yo
Average Age
Experienced Board: S1K's board of directors are considered experienced (3.8 years average tenure).